SCHEMBL9670326

SCHEMBL9670326

O=C(Oc1ccc(Cl)c(O)n1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.46
KMT2A Q03164 7/20 0.46
MEN1 O00255 3/20 0.44
LMNA P02545 3/20 0.43
METAP2 P50579 1/20 0.43
METAP1 P53582 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
F2 P00734 1/20 0.41
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
JAK2 O60674 1/20 0.40
USP2 O75604 1/20 0.40
GAA P10253 1/20 0.40
ALOX15 P16050 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9670785 0.84 MAPT (0.45) MAPTKMT2AMEN1LMNASMN1; SMN2
SCHEMBL9099386 0.80 MAPT (0.43) MAPTKMT2AMEN1LMNAMETAP2
SCHEMBL7773905 0.73 KMT2A (0.53) MAPTKMT2AMEN1LMNAMETAP2
SCHEMBL29403157 0.73 KMT2A (0.53) MAPTKMT2AMEN1LMNAMETAP2
SCHEMBL2884565 0.73 LMNA (0.52) MAPTKMT2AMEN1LMNASMN1; SMN2
SCHEMBL2762995 0.72 KMT2A (0.51) MAPTKMT2AMEN1LMNAMETAP2
SCHEMBL27633082 0.72 KMT2A (0.51) MAPTKMT2AMEN1LMNASMN1; SMN2
SCHEMBL9098804 0.72 KMT2A (0.41) MAPTKMT2AMEN1LMNAMETAP2
SCHEMBL9669695 0.71 KDM4E (0.46) MAPTKMT2AMEN1LMNAMETAP2
SCHEMBL31396932 0.70 LMNA (0.49) MAPTKMT2AMEN1LMNAMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US claimed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP claimed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP claimed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed